The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[2-Hydroxy-5-(1-hydroxy-2-{1-[4-(2-imino-5-oxo-imidazolidin-4-ylidenemethyl)-phenyl]-piperidin-4-ylamino}-ethyl)-phenyl]-methanesulfonamide ID: ALA174054
Chembl Id: CHEMBL174054
PubChem CID: 135995976
Max Phase: Preclinical
Molecular Formula: C24H30N6O5S
Molecular Weight: 514.61
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CS(=O)(=O)Nc1cc(C(O)CNC2CCN(c3ccc(/C=C4\N=C(N)NC4=O)cc3)CC2)ccc1O
Standard InChI: InChI=1S/C24H30N6O5S/c1-36(34,35)29-19-13-16(4-7-21(19)31)22(32)14-26-17-8-10-30(11-9-17)18-5-2-15(3-6-18)12-20-23(33)28-24(25)27-20/h2-7,12-13,17,22,26,29,31-32H,8-11,14H2,1H3,(H3,25,27,28,33)/b20-12-
Standard InChI Key: ZESZFZAGJRRLFK-NDENLUEZSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 514.61Molecular Weight (Monoisotopic): 514.1998AlogP: 0.84#Rotatable Bonds: 8Polar Surface Area: 169.38Molecular Species: BASEHBA: 9HBD: 6#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 7#RO5 Violations (Lipinski): 3CX Acidic pKa: 7.85CX Basic pKa: 9.47CX LogP: -0.99CX LogD: -1.26Aromatic Rings: 2Heavy Atoms: 36QED Weighted: 0.22Np Likeness Score: -0.78
References 1. Hu B, Malamas M, Ellingboe J, Largis E, Han S, Mulvey R, Tillett J.. (2001) New oxadiazolidinedione derivatives as potent and selective human beta3 agonists., 11 (8): [PMID:11327605 ] [10.1016/s0960-894x(01)00147-0 ]